Question · asked by 1 review
Transjugular intrahepatic portosystemic shunts vs Conventional treatment: Health‐related quality of life
- Population
- adults with hepatorenal syndrome
- Intervention
- Transjugular intrahepatic portosystemic shunts
- Comparison
- Conventional treatment
- Outcome
- Health‐related quality of life
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Transjugular intrahepatic portosystemic shunts vs conventional treatment Health‐related quality of life · adults with hepatorenal syndrome The review found no eligible studies for this question. Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome (2024) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Transjugular intrahepatic portosystemic shunts for adults with hepatorenal syndrome 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Transjugular intrahepatic portosystemic shunts vs endoscopic intervention with or without medical treatment · participants with cirrhosis and with previous oesophagogastric variceal bleeding · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.